Page 1

THRU ONLINE FILING Cipca A dose of life November 13 , 2021 BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code 524494 Dear Sirs , - National Stock Exchange India Limited , Exchange Plaza , C - 1 , Block - G , Bandra Kurla Complex , Bandra – ( East ) . Mumbai - 400051 . Scrip Code IPCALAB 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , we are enclosing herewith our Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Statutory Auditors thereon for the 2nd Quarter and half year ended 30th September , 2021 , which was taken on record at the Meeting of the Board of Directors of the Company held today at Mumbai . We are also enclosing herewith a press release issued by the Company in respect of its Q2 FY22 / H1 FY22 unaudited financial Results . 2. We wish to inform you that , the Board has declared an interim dividend of Rs . 8 / - per share ( 400 % ) for the financial year 2021-22 . Kindly note that vide our letter dated October 20 , 2021 , we have already informed you that 23rd Nov ember , 2021 has been fixed as the Record Date for ascertaining the members entitlement of said interim dividend now declared which will be paid by the Company to the eligible shareholders on or before 12th December , 2021 . 3. It is also further informed that the Board at its meeting held today has approved sub- division of every 1 ( one ) equity share of the nominal / face value of Rs . 2 / - each into 2 ( Two ) equity shares of the nominal / face value of Re . 1 / - each , subject to the approval of the shareholders at the Extra - Ordinary General Meeting scheduled to be held on 16th December , 2021 . The required disclosure under Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 regarding stock split is given hereinbelow : A. Split Ratio B. Rationale behind the split C. Pre and Post Share Capital Laboratories spca Limited of the 2 ( two ) equity shares nominal / face value of Re . 1 / - each for every 1 ( one ) equity share of the nominal / face value of Rs . 2 / - each held as on the record date to be decided . In order to improve the liquidity of the Company's share and to make it more affordable for small investors so as to broad base the small investors base As given below Ipca Laboratories Ltd. www.ipca.com 125 , KandivHndustrial Estate , CTS No. 328 , Kandivli ( West ) , Mumbai 400 067 , India | T : +91 22 6210 5000 F : +91 22 6210 5005 Regd . Office : 48 , Kandivli Industrial Estate , Kandivli ( West ) , Mumbai 400 067 , India | T : +91 22 6647 4444 F : +91 22 2868 6613 E : ipca@ipca.com | CIN : L24239MH1949PLC007837